Relationship between serum perlecan,neurociliin-1 levels and disease condition,perinatal outcome of gestational hypertension patients in late pregnancy
10.3969/j.issn.1673-4130.2024.04.022
- VernacularTitle:孕晚期妊娠期高血压患者血清串珠素、神经纤毛蛋白-1水平与病情、围生结局的关系
- Author:
Jinling ZHANG
1
;
Lihong GUO
;
Xiaojie WANG
Author Information
1. 邯郸市妇幼保健院产二科,河北邯郸 056002
- Keywords:
gestational hypertension;
late pregnancy;
perlecan;
neurociliin-1;
perinatal outcome
- From:
International Journal of Laboratory Medicine
2024;45(4):495-499
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the relationship between the levels of serum perlecan and neurociliin-1(NRP-1)and disease condition,perinatal outcome of gestational hypertension patients in late pregnancy.Meth-ods A total of 103 gestational hypertension patients in late pregnancy admitted to the hospital from January 2021 to January 2023 were selected as the subjects of this study.According to the severity of the disease,they were divided into simple hypertension group(n=46),mild eclampsia group(n=35)and severe eclampsia group(n=22).The perinatal outcomes of the patients were recorded and divided into good outcome group(n=72)and poor outcome group(n=31).Serum perlecan and NRP-1 levels were detected by enzyme-related immunosorbent assay,and the predictive value of serum perlecan and NRP-1 on perinatal outcomes in gesta-tional hypertension patients in late pregnancy was investigated by receiver operating characteristic(ROC)curve analysis.Multivariate Logistic regression analysis was used to investigate the influencing factors of peri-natal outcomes in gestational hypertension patients in late pregnancy.Results The serum levels of perlecan and NRP-1 in mild eclampsia group and severe eclampsia group were lower than those in simple hypertension group,and the difference was statistically significant(P＜0.05);Serum levels of perlecan and NRP-1 in severe eclampsia group were lower than those in mild eclampsia group,and the difference was statistically significant(P＜0.05).The serum levels of perlecan and NRP-1 in the good outcome group were higher than those in the bad outcome group,and the difference was statistically significant(P＜0.05).The clinical efficacy of serum perlecan and NRP-1 combined in predicting perinatal outcomes of gestational hypertension patients in late pregnancy was better than that of single index.The proportion of age≥35 years old,pre-pregnancy body mass index(BMI)≥24 kg/m2,history of abortion,systolic blood pressure,diastolic blood pressure and 24 h urinary protein in the adverse outcome group were higher than those in the good outcome group,and the differences were statistically significant(P＜0.05).Multivariate Logistic regression analysis showed that pre-pregnancy BMI≥24 kg/m2,history of abortion,high systolic blood pressure,perlecan≤8.63 nmol/L and RNP-1≤4.37 ng/mL were independent risk factors for adverse perinatal outcomes in gestational hypertension patients in late pregnancy(P＜0.05).Conclusion The decrease of serum perlecan and NRP-1 levels is associated with the aggravation of the disease and adverse perinatal outcomes in gestational hypertension patients in late preg-nancy,and the two indicators can be used as biological markers to predict the perinatal outcomes of patients.
